The “E” stands for “extranodal,” or outside the lymph nodes. Another early stage of lymphoma, stage 2, is diagnosed when you have cancer cells in two or more groups of lymph nodes either ...

The subtype of MZL was classified as extranodal MZL of mucosa-associated lymphoid tissue (MALT lymphoma), NMZL, and SMZL. 12 For the analysis proposal, all extranodal MZLs arising in different ...

Peripheral T-cell lymphomas are a rare and heterogeneous type of lymphoma, with geographical and ethnic variations in histological subtypes that differ across the world.1 In The Lancet Haematology, ...

T‑cell lymphomas, which often arise in extranodal lymphoid tissues, are highly aggressive and generally exhibit a poorer prognosis than their B‑cell counterparts with limited treatment options.

Our study underscores the unique epidemiological profile of peripheral T-cell lymphoma in Latin America, with a high ...

Brukinsa plus R-CHOP demonstrated high efficacy and durable responses in double-expressor lymphoma, with manageable safety, supporting further phase 3 trials.

The major symptoms of primary lymphoma of the bladder are intermittent hematuria, urinary frequency and dysuria. This disease presents as a solitary tumoral mass. A history of chronic cystitis has ...

Non-Hodgkin lymphoma is the 11th most common cause of cancer death in the UK, accounting for 3% of all cancer deaths (2017-2019).[1-4] In females in the UK, non-Hodgkin lymphoma is the 11th most ...

GC Cell (KRX:144510), under the leadership of CEO Sungyong Won, announced today the initiation of its domestic Phase 1 clinical trial for GCC2005 (AB‑205), a novel CD5 CAR‑NK cell therapy. This "first ...